Authors:
NEGRE D
OUDOT C
PROST JF
MURAKAMI K
ISHIHAMA A
COZZONE AJ
CORTAY JC
Citation: D. Negre et al., FRUR-MEDIATED TRANSCRIPTIONAL ACTIVATION AT THE PPSA PROMOTER OF ESCHERICHIA-COLI, Journal of Molecular Biology, 276(2), 1998, pp. 355-365
Authors:
NEGRE D
BONODBIDAUD C
OUDOT C
PROST JF
KOLB A
ISHIHAMA A
COZZONE AJ
CORTAY JC
Citation: D. Negre et al., DNA FLEXIBILITY OF THE UP ELEMENT IS A MAJOR DETERMINANT FOR TRANSCRIPTIONAL ACTIVATION AT THE ESCHERICHIA-COLI ACETATE PROMOTER, Nucleic acids research, 25(4), 1997, pp. 713-718
Authors:
PUECH A
MONTGOMERY SA
PROST JF
SOLLES A
BRILEY M
Citation: A. Puech et al., MILNACIPRAN, A NEW SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR - AN OVERVIEW OF ITS ANTIDEPRESSANT ACTIVITY AND CLINICAL TOLERABILITY, International clinical psychopharmacology, 12(2), 1997, pp. 99-108
Authors:
JAILLON P
DUPUIS B
DAHAN R
BOTTINEAU G
CARON J
CAZOR JL
CHAUVENET M
CLEMENT JP
ESCANDE D
FAISANDIER Y
FUNCKBRENTANO C
KOLSKY H
KOEN R
LACROIX D
LEENHARDT A
LEHNER JP
PROST JF
SWYNGHEDAUW B
VASSORT G
WEISSENBURGER J
WOHLHUTER C
Citation: P. Jaillon et al., DRUG-INDUCED TORSADE-DE-POINTES - PRECLIN ICAL AND CLINICAL-STUDIES FOR THE PREDICTION OF A POTENTIAL PROARRHYTHMIC ADVERSE DRUG REACTION, Therapie, 52(4), 1997, pp. 271-280
Authors:
LOPEZIBOR J
GUELFI JD
PLETAN Y
TOURNOUX A
PROST JF
Citation: J. Lopezibor et al., MILNACIPRAN AND SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN MAJOR DEPRESSION, International clinical psychopharmacology, 11, 1996, pp. 41-46
Citation: Sa. Montgomery et al., EFFICACY AND TOLERABILITY OF MILNACIPRAN - AN OVERVIEW, International clinical psychopharmacology, 11, 1996, pp. 47-51
Authors:
FELETOU M
ROBINEAU P
LONCHAMPT M
BONNARDEL E
THURIEAU C
FAUCHERE JL
WIDDOWSON P
MAHIEU JP
SERKIZ B
VOLLAND JP
MARTIN C
NALINE E
ADVENIER C
PROST JF
CANET E
Citation: M. Feletou et al., S-16118 (P-GUANIDOBENZOYL-[HYP(3),THI(5),D-TIC(7), OIC(8)]BRADYKININ)IS A POTENT AND LONG-ACTING BRADYKININ B2 RECEPTOR ANTAGONIST, IN-VITRO AND IN-VIVO, The Journal of pharmacology and experimental therapeutics, 273(3), 1995, pp. 1071-1077
Authors:
FELETOU M
LONCHAMPT M
ROBINEAU P
JAMONNEAU I
THURIEAU C
FAUCHERE JL
VILLA P
GHEZZI P
PROST JF
CANET E
Citation: M. Feletou et al., EFFECTS OF THE BRADYKININ B-2 RECEPTOR ANTAGONIST S-16118 BENZOYL-[HYP(3),THI(5),D-TIC(7),OIC(8)]BRADYKININ) IN DIFFERENT IN-VIVO ANIMAL-MODELS OF INFLAMMATION, The Journal of pharmacology and experimental therapeutics, 273(3), 1995, pp. 1078-1084
Authors:
ROBINEAU P
LONCHAMPT M
KUCHARCZYK N
KRAUSE JE
REGOLI D
FAUCHERE JL
PROST JF
CANET E
Citation: P. Robineau et al., IN-VITRO AND IN-VIVO PHARMACOLOGY OF S-16474, A NOVEL UAL TACHYKININ NK1 AND NK2 RECEPTOR ANTAGONIST, European journal of pharmacology, 294(2-3), 1995, pp. 677-684
Authors:
THURIEAU C
SIMONET S
PALADINO J
PROST JF
VERBEUREN T
FAUCHERE JL
Citation: C. Thurieau et al., NEW N-ALPHA-GUANIDINOBENZOYL DERIVATIVES OF HIRUDIN-54-65 CONTAINING STABILIZED CARBOXYL OR PHOSPHORYL GROUPS ON THE SIDE-CHAIN OF PHENYLALANINE-63, Journal of medicinal chemistry, 37(5), 1994, pp. 625-629
Authors:
JASZTOLDHOWORKO R
LANDRAS C
PIERRE A
ATASSI G
GUILBAUD N
KRAUSBERTHIER L
LEONCE S
ROLLAND Y
PROST JF
BISAGNI E
Citation: R. Jasztoldhoworko et al., SYNTHESIS AND EVALUATION OF 9-HYDROXY-5-METHYL-(AND B]CARBAZOLE-1-N-[(DIALKYLAMINO)ALKYL]CARBOXAMIDES, A NEW PROMISING SERIES OF ANTITUMOR OLIVACINE DERIVATIVES, Journal of medicinal chemistry, 37(15), 1994, pp. 2445-2452
Authors:
MILLAN MJ
AUDINOT V
RIVET JM
GOBERT A
VIAN J
PROST JF
SPEDDING M
PEGLION JL
Citation: Mj. Millan et al., S-14297, A NOVEL SELECTIVE LIGAND AT CLONED HUMAN DOPAMINE-D-3 RECEPTORS, BLOCKS 7-OH-DPAT-INDUCED HYPOTHERMIA IN RATS, European journal of pharmacology, 260(2-3), 1994, pp. 180000003-180000005
Authors:
THOLLON C
CAMBARRAT C
VIAN J
PROST JF
PEGLION JL
VILAINE JP
Citation: C. Thollon et al., ELECTROPHYSIOLOGICAL EFFECTS OF S-16257, A NOVEL SINOATRIAL NODE MODULATOR, ON RABBIT AND GUINEA-PIG CARDIAC PREPARATIONS - COMPARISON WITHUL-FS-49, British Journal of Pharmacology, 112(1), 1994, pp. 37-42